Sign inGet started

Gunderson Robert V JR

Insider CIK 1302450 · THRX Director · VTAE Director · TBPH Director · ANDG Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
ANDG Andersen Group Inc. P Buy2026-05-202026-05-222,367$35.82 $84.8K15,000SEC↗
ANDG Andersen Group Inc. P Buy2025-12-182025-12-2212,633$16.00 $202.1K12,633SEC↗
TBPH Theravance Biopharma, Inc. A Award deriv2021-04-272021-04-296,000— $06,000SEC↗
TBPH Theravance Biopharma, Inc. A Award2021-04-272021-04-299,828— $068,093SEC↗
TBPH Theravance Biopharma, Inc. A Award deriv2020-04-282020-04-306,000— $06,000SEC↗
TBPH Theravance Biopharma, Inc. A Award2020-04-282020-04-306,635— $058,265SEC↗
TBPH Theravance Biopharma, Inc. A Award deriv2019-04-302019-05-026,000— $06,000SEC↗
TBPH Theravance Biopharma, Inc. A Award2019-04-302019-05-028,385— $051,630SEC↗
TBPH Theravance Biopharma, Inc. A Award deriv2018-05-012018-05-036,000— $06,000SEC↗
TBPH Theravance Biopharma, Inc. A Award2018-05-012018-05-038,186— $043,245SEC↗
TBPH Theravance Biopharma, Inc. A Award2017-05-172017-05-186,000— $035,059SEC↗
VTAE Vitae Pharmaceuticals, Inc D To issuer deriv2016-10-252016-10-2510,000$11.38 $113.8K0SEC↗
VTAE Vitae Pharmaceuticals, Inc D To issuer deriv2016-10-252016-10-2510,000$8.57 $85.7K0SEC↗
VTAE Vitae Pharmaceuticals, Inc D To issuer deriv2016-10-252016-10-255,434$17.09 $92.9K0SEC↗
VTAE Vitae Pharmaceuticals, Inc D To issuer deriv2016-10-252016-10-259,091$15.71 $142.8K0SEC↗
VTAE Vitae Pharmaceuticals, Inc D To issuer deriv2016-10-252016-10-2517,000$13.00 $221.0K0SEC↗
VTAE Vitae Pharmaceuticals, Inc U Tender2016-10-242016-10-2515,830$21.00 $332.4K0SEC↗
VTAE Vitae Pharmaceuticals, Inc U Tender2016-10-242016-10-2511,002$21.00 $231.0K0SEC↗
VTAE Vitae Pharmaceuticals, Inc A Award deriv2016-05-262016-05-2710,000— $010,000SEC↗
TBPH Theravance Biopharma, Inc. A Award2016-05-032016-05-056,000— $029,059SEC↗
VTAE Vitae Pharmaceuticals, Inc A Award deriv2015-05-282015-06-0110,000— $010,000SEC↗
TBPH Theravance Biopharma, Inc. A Award2015-04-222015-04-246,000— $033,906SEC↗
VTAE Vitae Pharmaceuticals, Inc C Conversion deriv2014-09-292014-10-014,347— $00SEC↗
VTAE Vitae Pharmaceuticals, Inc C Conversion deriv2014-09-292014-10-014,454— $00SEC↗
VTAE Vitae Pharmaceuticals, Inc C Conversion2014-09-292014-10-014,454— $011,002SEC↗
VTAE Vitae Pharmaceuticals, Inc C Conversion2014-09-292014-10-016,548— $06,548SEC↗
VTAE Vitae Pharmaceuticals, Inc A Award deriv2014-09-242014-09-2617,000— $017,000SEC↗
TBPH Theravance Biopharma, Inc. A Award deriv2014-06-032014-06-0512,000— $012,000SEC↗
TBPH Theravance Biopharma, Inc. A Award deriv2014-06-032014-06-0512,000— $012,000SEC↗
THRX THERAVANCE INC A Award deriv2014-05-222014-05-276,000— $06,000SEC↗
THRX THERAVANCE INC A Award2014-05-222014-05-276,000— $0115,970SEC↗
THRX THERAVANCE INC M Exercise deriv2014-04-172014-04-2125,806— $00SEC↗
THRX THERAVANCE INC M Exercise2014-04-172014-04-2125,806$9.69 $250.1K109,970SEC↗
THRX THERAVANCE INC A Award deriv2013-04-242013-04-266,000— $06,000SEC↗
THRX THERAVANCE INC A Award2013-04-242013-04-266,000— $084,164SEC↗
THRX THERAVANCE INC A Award deriv2012-05-152012-05-176,000— $06,000SEC↗
THRX THERAVANCE INC A Award2012-05-152012-05-176,000— $078,164SEC↗